Stem cells for pancreatic β-cell replacement in diabetes mellitus
Authors:
- Pia MontanucciPMPia Montanucci
- Giuseppe BastaGBGiuseppe Basta
- 1 April 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 19 (2) , 162-168
Abstract
Type 1 and type 2 diabetes mellitus represent a widespread metabolic disorder, related to autoimmune β-cell destruction and insulin resistance, leading to β-cell dysfunction, respectively, that are associated with severe chronic complications with irreversible multiorgan morphological and functional damage. Conventional treatment, based on exogenous insulin or oral agents may control and delay but not prevent the disease complications, which has lead, so far, to a steady increase in mortality and morbidity. β-Cell substitution cell therapy, initially pursued by whole pancreatic and isolated islet transplantation, with scarce and limited efficiency, now is looking at the new technologies for cell and molecular therapy for diabetes, based on stem cells. Pancreatic endocrine cells regeneration might replenish the destroyed β-cell pool, with neogenerated β-cell derived from pancreatic and extrapancreatic stem cell sources. Additionally, embryonic or adult stem cells derived from different cell lineages, and able to differentiate into β-like cell elements, may not only restore the original insulin secretory patterns but also exert the immunomodulatory effects aimed at interrupting the β-cell-directed autoimmune destruction vicious cycle. These new strategies may, one day, provide for the final cure of diabetes mellitus.Keywords
This publication has 65 references indexed in Scilit:
- β-Cell regeneration: the pancreatic intrinsic facultyTrends in Endocrinology & Metabolism, 2011
- Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in CultureCell Stem Cell, 2011
- Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of InjectionStem Cells, 2010
- Generation of pluripotent stem cells from patients with type 1 diabetesProceedings of the National Academy of Sciences, 2009
- The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β CellsCell, 2009
- Morality and human embryo researchEMBO Reports, 2009
- Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cellsDevelopmental Biology, 2008
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998